CH GH70 VESOUL
- Address
- 2 Rue René Heymes, 70000 Vesoul, France
CH GH70 VESOUL - Diabetes Research Center
CH GH70 VESOUL is a specialized clinical research center focused on advancing treatment approaches for complex diabetes presentations. The center demonstrates particular expertise in investigating metabolic disorders and innovative pharmacological interventions for patients with challenging glycemic control patterns.
- Double diabetes treatment strategies combining type 1 and type 2 diabetes characteristics
- GLP-1 receptor agonist therapy optimization in insulin-dependent patients
- Continuous glucose monitoring and time-in-range outcome studies
The research center is actively conducting investigations into double diabetes, a complex condition where patients with type 1 diabetes develop insulin resistance features typical of type 2 diabetes. Their current work evaluates the efficacy of semaglutide, a weekly GLP-1 agonist, as an adjunctive treatment to standard insulin therapy, with a focus on improving glycemic time-in-range outcomes over six-month treatment periods.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Centre Hospitalier De Versailles1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in CH GH70 VESOUL
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Efficacy of Amoxicillin-Clavulanic Acid Versus Amoxicillin-Clavulanic Acid Plus Ciprofloxacin in Chemotherapy-Induced Fever in Adult Hematology Patients | Centre Hospitalier De Versailles | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Amoxicillin Sodium | 1 | Unknown | — | — |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.